Skip to main content
PMC home page
Heart logoLink to Heart
. 1999 May;81(5):546–555.

Investigation and management of stable angina: revised guidelines 1998

D de Bono
PMCID: PMC1729032  PMID: 10212177

Full Text

The Full Text of this article is available as a PDF (136.3 KB).

Figure 1  .

Figure 1  

Open in a new tab

Algorithm of investigation in stable angina. CHD, coronary heart disease; MPI, myocardial perfusion imaging.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. M., Wilson P. W., Odell P. M., Kannel W. B. An updated coronary risk profile. A statement for health professionals. Circulation. 1991 Jan;83(1):356–362. doi: 10.1161/01.cir.83.1.356. [DOI] [PubMed] [Google Scholar]
  2. Barrett-Connor E., Khaw K. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation. 1984 Jun;69(6):1065–1069. doi: 10.1161/01.cir.69.6.1065. [DOI] [PubMed] [Google Scholar]
  3. Black N., Langham S., Coshall C., Parker J. Impact of the 1991 NHS reforms on the availability and use of coronary revascularisation in the UK (1987-1995) Heart. 1996 Dec;76(4 Suppl 4):1–31. doi: 10.1136/hrt.76.4_suppl_4.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Braunwald E., Jones R. H., Mark D. B., Brown J., Brown L., Cheitlin M. D., Concannon C. A., Cowan M., Edwards C., Fuster V. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation. 1994 Jul;90(1):613–622. doi: 10.1161/01.cir.90.1.613. [DOI] [PubMed] [Google Scholar]
  5. Brown K. A., Boucher C. A., Okada R. D., Guiney T. E., Newell J. B., Strauss H. W., Pohost G. M. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol. 1983 Apr;1(4):994–1001. doi: 10.1016/s0735-1097(83)80100-4. [DOI] [PubMed] [Google Scholar]
  6. Brown K. A. Prognostic value of myocardial perfusion imaging: state of the art and new developments. J Nucl Cardiol. 1996 Nov-Dec;3(6 Pt 1):516–537. doi: 10.1016/s1071-3581(96)90061-6. [DOI] [PubMed] [Google Scholar]
  7. Brown K. A. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation. 1991 Feb;83(2):363–381. doi: 10.1161/01.cir.83.2.363. [DOI] [PubMed] [Google Scholar]
  8. Bruce R. A., Hossack K. F., DeRouen T. A., Hofer V. Enhanced risk assessment for primary coronary heart disease events by maximal exercise testing: 10 years' experience of Seattle Heart Watch. J Am Coll Cardiol. 1983 Sep;2(3):565–573. doi: 10.1016/s0735-1097(83)80286-1. [DOI] [PubMed] [Google Scholar]
  9. Cannon P. J., Connell P. A., Stockley I. H., Garner S. T., Hampton J. R. Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet. 1988 Apr 30;1(8592):979–981. doi: 10.1016/s0140-6736(88)91790-4. [DOI] [PubMed] [Google Scholar]
  10. Chester M. R., Chen L., Tousoulis D., Poloniecki J., Kaski J. C. Differential progression of complex and smooth stenoses within the same coronary tree in men with stable coronary artery disease. J Am Coll Cardiol. 1995 Mar 15;25(4):837–842. doi: 10.1016/0735-1097(94)00472-3. [DOI] [PubMed] [Google Scholar]
  11. Chrysant S. G., Glasser S. P., Bittar N., Shahidi F. E., Danisa K., Ibrahim R., Watts L. E., Garutti R. J., Ferraresi R., Casareto R. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol. 1993 Dec 1;72(17):1249–1256. doi: 10.1016/0002-9149(93)90292-k. [DOI] [PubMed] [Google Scholar]
  12. Cox J., Naylor C. D. The Canadian Cardiovascular Society grading scale for angina pectoris: is it time for refinements? Ann Intern Med. 1992 Oct 15;117(8):677–683. doi: 10.7326/0003-4819-117-8-677. [DOI] [PubMed] [Google Scholar]
  13. Dargie H. J., Ford I., Fox K. M. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group. Eur Heart J. 1996 Jan;17(1):104–112. doi: 10.1093/oxfordjournals.eurheartj.a014668. [DOI] [PubMed] [Google Scholar]
  14. Detrano R., Gianrossi R., Froelicher V. The diagnostic accuracy of the exercise electrocardiogram: a meta-analysis of 22 years of research. Prog Cardiovasc Dis. 1989 Nov-Dec;32(3):173–206. doi: 10.1016/0033-0620(89)90025-x. [DOI] [PubMed] [Google Scholar]
  15. Egstrup K. Randomized double-blind comparison of metoprolol, nifedipine, and their combination in chronic stable angina: effects on total ischemic activity and heart rate at onset of ischemia. Am Heart J. 1988 Oct;116(4):971–978. doi: 10.1016/0002-8703(88)90147-0. [DOI] [PubMed] [Google Scholar]
  16. Froelicher V. F., Jr, Thompson A. J., Wolthuis R., Fuchs R., Balusek R., Longo M. R., Jr, Triebwasser J. H., Lancaster M. C. Angiographic findings in asymptomatic aircrewmen with electrocardiographic abnormalities. Am J Cardiol. 1977 Jan;39(1):32–38. doi: 10.1016/s0002-9149(77)80007-6. [DOI] [PubMed] [Google Scholar]
  17. Gibbs J. S., McAlpine H. M., Wright C., McLenachan J. M., Sparrow J., Sutton G., Dargie H. J., Fox K. M. Double-blind randomised placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina. Int J Cardiol. 1991 Jun;31(3):281–286. doi: 10.1016/0167-5273(91)90378-3. [DOI] [PubMed] [Google Scholar]
  18. Gray D., Hampton J. R. Methods of establishing criteria for purchasing coronary angiography in the investigation of chest pain. J Public Health Med. 1994 Dec;16(4):399–405. doi: 10.1093/oxfordjournals.pubmed.a043020. [DOI] [PubMed] [Google Scholar]
  19. Gray D., Hampton J. R. Methods of establishing criteria for purchasing coronary angiography in the investigation of chest pain. J Public Health Med. 1994 Dec;16(4):399–405. doi: 10.1093/oxfordjournals.pubmed.a043020. [DOI] [PubMed] [Google Scholar]
  20. Gray D., Hampton J. R. Variations in the use of coronary angiography in three cities in the Trent Region. Br Heart J. 1994 May;71(5):474–478. doi: 10.1136/hrt.71.5.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Guidelines for cardiac exercise testing. ESC Working Group on Exercise Physiology, Physiopathology and Electrocardiography. Eur Heart J. 1993 Jul;14(7):969–988. [PubMed] [Google Scholar]
  22. Hadorn D. C., Holmes A. C. The New Zealand priority criteria project. Part 2: Coronary artery bypass graft surgery. BMJ. 1997 Jan 11;314(7074):135–138. doi: 10.1136/bmj.314.7074.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hadorn D. C., Holmes A. C. The New Zealand priority criteria project. Part 2: Coronary artery bypass graft surgery. BMJ. 1997 Jan 11;314(7074):135–138. doi: 10.1136/bmj.314.7074.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Henderson R. A., Pocock S. J., Sharp S. J., Nanchahal K., Sculpher M. J., Buxton M. J., Hampton J. R. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet. 1998 Oct 31;352(9138):1419–1425. doi: 10.1016/s0140-6736(98)03358-3. [DOI] [PubMed] [Google Scholar]
  25. Juul-Möller S., Edvardsson N., Jahnmatz B., Rosén A., Sørensen S., Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet. 1992 Dec 12;340(8833):1421–1425. doi: 10.1016/0140-6736(92)92619-q. [DOI] [PubMed] [Google Scholar]
  26. Kannel W. B., Feinleib M. Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol. 1972 Feb;29(2):154–163. doi: 10.1016/0002-9149(72)90624-8. [DOI] [PubMed] [Google Scholar]
  27. Kannel W. B., McGee D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035–2038. doi: 10.1001/jama.241.19.2035. [DOI] [PubMed] [Google Scholar]
  28. Kaul S., Finkelstein D. M., Homma S., Leavitt M., Okada R. D., Boucher C. A. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol. 1988 Jul;12(1):25–34. doi: 10.1016/0735-1097(88)90351-8. [DOI] [PubMed] [Google Scholar]
  29. Knight C., Purcell H., Fox K. Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil. Cardiovasc Drugs Ther. 1995 Mar;9 (Suppl 2):229–236. doi: 10.1007/BF00878470. [DOI] [PubMed] [Google Scholar]
  30. Ladenheim M. L., Kotler T. S., Pollock B. H., Berman D. S., Diamond G. A. Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease. Am J Cardiol. 1987 Feb 1;59(4):270–277. doi: 10.1016/0002-9149(87)90798-3. [DOI] [PubMed] [Google Scholar]
  31. Ladenheim M. L., Pollock B. H., Rozanski A., Berman D. S., Staniloff H. M., Forrester J. S., Diamond G. A. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986 Mar;7(3):464–471. doi: 10.1016/s0735-1097(86)80454-5. [DOI] [PubMed] [Google Scholar]
  32. Lim R., Kreidieh I., Dyke L., Thomas J., Dymond D. S. Exercise testing without interruption of medication for refining the selection of mildly symptomatic patients for prognostic coronary angiography. Br Heart J. 1994 Apr;71(4):334–340. doi: 10.1136/hrt.71.4.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. MacRae C. A., Marber M. S., Keywood C., Joy M. Need for invasive cardiological assessment and intervention: a ten year review. Br Heart J. 1992 Feb;67(2):200–203. doi: 10.1136/hrt.67.2.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mark D. B., Nelson C. L., Califf R. M., Harrell F. E., Jr, Lee K. L., Jones R. H., Fortin D. F., Stack R. S., Glower D. D., Smith L. R. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994 May;89(5):2015–2025. doi: 10.1161/01.cir.89.5.2015. [DOI] [PubMed] [Google Scholar]
  35. Mark D. B., Shaw L., Harrell F. E., Jr, Hlatky M. A., Lee K. L., Bengtson J. R., McCants C. B., Califf R. M., Pryor D. B. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med. 1991 Sep 19;325(12):849–853. doi: 10.1056/NEJM199109193251204. [DOI] [PubMed] [Google Scholar]
  36. Melin J. A., Wijns W., Vanbutsele R. J., Robert A., De Coster P., Brasseur L. A., Beckers C., Detry J. M. Alternative diagnostic strategies for coronary artery disease in women: demonstration of the usefulness and efficiency of probability analysis. Circulation. 1985 Mar;71(3):535–542. doi: 10.1161/01.cir.71.3.535. [DOI] [PubMed] [Google Scholar]
  37. Miranda C. P., Lehmann K. G., Froelicher V. F. Correlation between resting ST segment depression, exercise testing, coronary angiography, and long-term prognosis. Am Heart J. 1991 Dec;122(6):1617–1628. doi: 10.1016/0002-8703(91)90279-q. [DOI] [PubMed] [Google Scholar]
  38. Morise A. P., Detrano R., Bobbio M., Diamond G. A. Development and validation of a logistic regression-derived algorithm for estimating the incremental probability of coronary artery disease before and after exercise testing. J Am Coll Cardiol. 1992 Nov 1;20(5):1187–1196. doi: 10.1016/0735-1097(92)90377-y. [DOI] [PubMed] [Google Scholar]
  39. Nidorf S. M., Parsons R. W., Thompson P. L., Jamrozik K. D., Hobbs M. S. Reduced risk of death at 28 days in patients taking a beta blocker before admission to hospital with myocardial infarction. BMJ. 1990 Jan 13;300(6717):71–74. doi: 10.1136/bmj.300.6717.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Noonan S. J., Cook J. L., Keller C. E., Rosenkrans C. M., Healy J. M., Jr, Feingold L., Schoenbaum S. C. Relationship of anatomic disease to appropriateness ratings of coronary angiography. Arch Intern Med. 1995 Jun 12;155(11):1209–1213. [PubMed] [Google Scholar]
  41. Parisi A. F., Folland E. D., Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med. 1992 Jan 2;326(1):10–16. doi: 10.1056/NEJM199201023260102. [DOI] [PubMed] [Google Scholar]
  42. Parker J. O. Eccentric dosing with isosorbide-5-mononitrate in angina pectoris. Am J Cardiol. 1993 Oct 15;72(12):871–876. doi: 10.1016/0002-9149(93)91098-3. [DOI] [PubMed] [Google Scholar]
  43. Pepine C. J., Cohn P. F., Deedwania P. C., Gibson R. S., Handberg E., Hill J. A., Miller E., Marks R. G., Thadani U. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation. 1994 Aug;90(2):762–768. doi: 10.1161/01.cir.90.2.762. [DOI] [PubMed] [Google Scholar]
  44. Pocock S. J., Henderson R. A., Rickards A. F., Hampton J. R., King S. B., 3rd, Hamm C. W., Puel J., Hueb W., Goy J. J., Rodriguez A. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet. 1995 Nov 4;346(8984):1184–1189. doi: 10.1016/s0140-6736(95)92897-9. [DOI] [PubMed] [Google Scholar]
  45. Ramsay L. E., Haq I. U., Jackson P. R., Yeo W. W., Pickin D. M., Payne J. N. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet. 1996 Aug 10;348(9024):387–388. doi: 10.1016/s0140-6736(96)05516-x. [DOI] [PubMed] [Google Scholar]
  46. Rozanski A., Berman D. S. The efficacy of cardiovascular nuclear medicine exercise studies. Semin Nucl Med. 1987 Apr;17(2):104–120. doi: 10.1016/s0001-2998(87)80016-8. [DOI] [PubMed] [Google Scholar]
  47. Rubens F., Goldstein W., Hickey N., Dennie C., Keon W. Hoarseness secondary to left atrial myxoma. Chest. 1989 May;95(5):1139–1140. doi: 10.1378/chest.95.5.1139. [DOI] [PubMed] [Google Scholar]
  48. Schömig A., Neumann F. J., Kastrati A., Schühlen H., Blasini R., Hadamitzky M., Walter H., Zitzmann-Roth E. M., Richardt G., Alt E. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996 Apr 25;334(17):1084–1089. doi: 10.1056/NEJM199604253341702. [DOI] [PubMed] [Google Scholar]
  49. Shaper A. G., Cook D. G., Walker M., Macfarlane P. W. Prevalence of ischaemic heart disease in middle aged British men. Br Heart J. 1984 Jun;51(6):595–605. doi: 10.1136/hrt.51.6.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Smith W. C., Kenicer M. B., Tunstall-Pedoe H., Clark E. C., Crombie I. K. Prevalence of coronary heart disease in Scotland: Scottish Heart Health Study. Br Heart J. 1990 Nov;64(5):295–298. doi: 10.1136/hrt.64.5.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Steffensen R., Grande P., Pedersen F., Haunsø S. Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia. Int J Cardiol. 1993 Jul 1;40(2):143–153. doi: 10.1016/0167-5273(93)90277-n. [DOI] [PubMed] [Google Scholar]
  52. Stephens N. G., Parsons A., Schofield P. M., Kelly F., Cheeseman K., Mitchinson M. J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet. 1996 Mar 23;347(9004):781–786. doi: 10.1016/s0140-6736(96)90866-1. [DOI] [PubMed] [Google Scholar]
  53. Stone P. H., Gibson R. S., Glasser S. P., DeWood M. A., Parker J. D., Kawanishi D. T., Crawford M. H., Messineo F. C., Shook T. L., Raby K. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group. Circulation. 1990 Dec;82(6):1962–1972. doi: 10.1161/01.cir.82.6.1962. [DOI] [PubMed] [Google Scholar]
  54. Thadani U., Glasser S., Bittar N., Beach C. L. Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group. Am J Cardiol. 1994 Jul 1;74(1):9–17. doi: 10.1016/0002-9149(94)90483-9. [DOI] [PubMed] [Google Scholar]
  55. The investigation and management of stable angina. Report of a working party of the Joint Audit Committee of the British Cardiac Society and the Royal College of Physicians of London. J R Coll Physicians Lond. 1993 Jul;27(3):267–273. [PMC free article] [PubMed] [Google Scholar]
  56. Thompson D. R., Bowman G. S., Kitson A. L., de Bono D. P., Hopkins A. Cardiac rehabilitation in the United Kingdom: guidelines and audit standards. National Institute for Nursing, the British Cardiac Society and the Royal College of Physicians of London. Heart. 1996 Jan;75(1):89–93. doi: 10.1136/hrt.75.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Versaci F., Gaspardone A., Tomai F., Crea F., Chiariello L., Gioffrè P. A. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med. 1997 Mar 20;336(12):817–822. doi: 10.1056/NEJM199703203361201. [DOI] [PubMed] [Google Scholar]
  58. Wallén N. H., Held C., Rehnqvist N., Hjemdahl P. Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris. Am J Cardiol. 1995 Jan 1;75(1):1–6. doi: 10.1016/s0002-9149(99)80516-5. [DOI] [PubMed] [Google Scholar]
  59. Yusuf S., Zucker D., Peduzzi P., Fisher L. D., Takaro T., Kennedy J. W., Davis K., Killip T., Passamani E., Norris R. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994 Aug 27;344(8922):563–570. doi: 10.1016/s0140-6736(94)91963-1. [DOI] [PubMed] [Google Scholar]
  60. de Bono D. Complications of diagnostic cardiac catheterisation: results from 34,041 patients in the United Kingdom confidential enquiry into cardiac catheter complications. The Joint Audit Committee of the British Cardiac Society and Royal College of Physicians of London. Br Heart J. 1993 Sep;70(3):297–300. doi: 10.1136/hrt.70.3.297. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES